Ionomycin Exhibits Potent and Selective Bactericidal Activity Against Clostridioides difficile Through Calcium‐Dependent Membrane Disruption
MicrobiologyOpen · 2026-04 · 15 (2)
DOI: 10.1002/mbo3.70269 ↗Kurz gefasst
Fachartikel in der Zeitschrift MicrobiologyOpen, online erschienen am 17.03.2026. Verfasst von Ahmed A Abouelkhair und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State Univer…. Hauptthemen laut MEDLINE: Clostridioides difficile, Anti-Bacterial Agents, Calcium, Cell Membrane. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Clostridioides difficile represents a critical global health concern due to its high morbidity, mortality, and recurrent infections associated with current therapeutic options. There is an urgent need for novel, selective anti‐ C. difficile therapeutic agents. Screening the microbial metabolite library against C. difficile identified ionomycin, a calcium ionophore produced by Streptomyces conglobatus , as a potent inhibitor for C. difficile . Ionomycin exhibited potent activity against 30 C. difficile isolates, with minimum inhibitory concentrations of 1 μg/mL and 2 μg/mL against 50% (MIC 50 ) and 90% (MIC 90 ) of isolates, respectively. Time‐kill assays revealed rapid bactericidal activity, achieving a ≥ 3 log₁₀ reduction within 8 h, surpassing the efficacy of vancomycin and fidaxomicin. At subinhibitory concentrations, ionomycin markedly reduced toxin production (~20%) and spore formation (~3 log 10 CFU/mL). Moreover, ionomycin exerted a potent activity against C. difficile spore germination and significantly prevented the toxin production from the germinating C. difficile cells. Importantly, ionomycin displayed limited activity against representative gut microbiota strains, indicating a favorable selectivity profile. Mechanistic investigations revealed a calcium‐dependent mode of action, as exogenous calcium enhanced ionomycin‐mediated bactericidal activity, whereas calcium chelation attenuated its effects. Consistent with this mechanism, ionomycin disrupted C. difficile membrane potential, an effect that was further potentiated by calcium supplementation. Collectively, these findings identify ionomycin as a potent and selective anti‐ C. difficile agent with a distinct calcium‐dependent mechanism of action, supporting its potential as a promising therapeutic candidate warranting further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA.
- Center for One Health Research, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA.
- Department of Microbiology and Immunology, Faculty of Pharmacy, Zagazig University, Zagazig, Al-Sharqia, Egypt.
ORCID-Profile: Ahmed A Abouelkhair
Förderung
- NIH HHS
- National Institutes of Health
Zitieren
APA
Abouelkhair, A. A., Abutaleb, N. S., & Seleem, M. N. (2026). Ionomycin Exhibits Potent and Selective Bactericidal Activity Against Clostridioides difficile Through Calcium‐Dependent Membrane Disruption. MicrobiologyOpen, 15(2). https://doi.org/10.1002/mbo3.70269
Vancouver
Abouelkhair AA, Abutaleb NS, Seleem MN. Ionomycin Exhibits Potent and Selective Bactericidal Activity Against Clostridioides difficile Through Calcium‐Dependent Membrane Disruption. MicrobiologyOpen. 2026;15(2). doi:10.1002/mbo3.70269
BibTeX
@article{Abouelkhair2026,
author = {Abouelkhair, Ahmed A and Abutaleb, Nader S and Seleem, Mohamed N},
title = {Ionomycin Exhibits Potent and Selective Bactericidal Activity Against Clostridioides difficile Through Calcium‐Dependent Membrane Disruption},
journal = {MicrobiologyOpen},
year = {2026},
volume = {15},
number = {2},
doi = {10.1002/mbo3.70269}
}
EUVIMED